207 related articles for article (PubMed ID: 1509205)
1. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
2. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
3. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
5. Effects of vanadyl sulfate on kidney in experimental diabetes.
Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
[TBL] [Abstract][Full Text] [Related]
6. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
7. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
8. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
Koyuturk M; Tunali S; Bolkent S; Yanardag R
Biol Trace Elem Res; 2005 Jun; 104(3):233-47. PubMed ID: 15930593
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
10. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Thompson KH; Leichter J; McNeill JH
Biochem Biophys Res Commun; 1993 Dec; 197(3):1549-55. PubMed ID: 8280174
[TBL] [Abstract][Full Text] [Related]
11. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
12. Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.
Kurt O; Ozden TY; Ozsoy N; Tunali S; Can A; Akev N; Yanardag R
Biometals; 2011 Oct; 24(5):943-9. PubMed ID: 21479831
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
15. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
16. Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta.
Akgün-Dar K; Bolkent S; Yanardag R; Tunali S
Cell Biochem Funct; 2007; 25(6):603-9. PubMed ID: 16892454
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
18. Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats.
Thompson KH; McNeill JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):187-200. PubMed ID: 8100638
[TBL] [Abstract][Full Text] [Related]
19. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Ramanadham S; Mongold JJ; Brownsey RW; Cros GH; McNeill JH
Am J Physiol; 1989 Sep; 257(3 Pt 2):H904-11. PubMed ID: 2675634
[TBL] [Abstract][Full Text] [Related]
20. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
Cam MC; Brownsey RW; Rodrigues B; McNeill JH
Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]